Home » Stocks » GCAN

The Greater Cannabis Company, Inc. (GCAN)

Stock Price: $0.0079 USD 0.0015 (23.44%)
Updated May 13, 2021 11:00 AM EDT - Market open
Market Cap 3.40M
Revenue (ttm) 48,044
Net Income (ttm) -951,170
Shares Out 478.64M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 13
Last Price $0.0079
Previous Close $0.0064
Change ($) 0.0015
Change (%) 23.44%
Day's Open 0.0077
Day's Range 0.0076 - 0.0080
Day's Volume 219,500
52-Week Range 0.0018 - 0.0241

News

Hide News

BALTIMORE, March 16, 2021 (GLOBE NEWSWIRE) -- Greater Cannabis Company ( OTCQB: GCAN ), an innovator in the development and commercialization of cannabinoid delivery systems and cannabinoid products is ...

1 month ago - GlobeNewsWire

BALTIMORE, MD, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The Greater Cannabis Company (GCAN), an innovator in the development and commercialization of cannabinoid delivery systems and cannabinoid products today...

3 months ago - GlobeNewsWire

About GCAN

The Greater Cannabis Company, Inc., a biopharmaceutical company, focuses on the development and commercialization of technology for transmucosal delivery of legal medical or recreational cannabis and cannabinoids. The company's initial product is an oral transmucosal patch platform, which provides loaded actives to be absorbed by the buccal mucosa into the body. It intends to commercialize the technology by sublicensing or partnering with licensed producers, distributors, processors, consumer product, and pharmaceutical companies. The company w... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
Stock Exchange
OTCMKTS
Ticker Symbol
GCAN
Full Company Profile

Financial Performance

In 2020, GCAN's revenue was $48,044, an increase of 574.78% compared to the previous year's $7,120. Losses were -$951,170, -42.30% less than in 2019.

Financial Statements